Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Platz

Showing results (501-510 of 590) with videos related to

Pageof 59
Sort By:
Plos One|June 30, 2021
GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United StatesIgor Vidal, Qizhi Zheng, Jessica L Hicks, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
The Association between Proteomic Aging Clocks and the Risk of Cancer in Midlife IndividualsShuo Wang, Zexi Rao, Aixin Li, et al.
Cancer & Metabolism|September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2015
Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancerM H Umbehr, B Gurel, T J Murtola, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcomePaula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Carcinogenesis|July 21, 2011
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Song Yao, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2015
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention TrialTeemu J Murtola, Bora Gurel, Martin Umbehr, et al.
Journal of the National Cancer Institute|March 11, 2026
Divergent effects of PLA2G7 on prostate cancer biochemical recurrence in european American and african American menChanning J Paller, Shuanzeng Wei, Megan Schumacher, et al.
Carcinogenesis|December 12, 2017
Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Mary E Platek, Song Yao, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Identifying Plasma Proteins Associated with Risk of Solid Cancers: A 25-Year Prospective Analysis of 4,712 Circulating Proteins in the ARIC StudyZiqiao Wang, Vernon Burk, Zhe Huang, et al.
Pageof 59

Showing results (501-510 of 590) with videos related to

Sort By:
Pageof 59
Plos One|June 30, 2021
GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United StatesIgor Vidal, Qizhi Zheng, Jessica L Hicks, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
The Association between Proteomic Aging Clocks and the Risk of Cancer in Midlife IndividualsShuo Wang, Zexi Rao, Aixin Li, et al.
Cancer & Metabolism|September 28, 2018
CD38 is methylated in prostate cancer and regulates extracellular NAD<sup></sup>Jack Mottahedeh, Michael C Haffner, Tristan R Grogan, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2015
Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancerM H Umbehr, B Gurel, T J Murtola, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcomePaula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Carcinogenesis|July 21, 2011
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Song Yao, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2015
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention TrialTeemu J Murtola, Bora Gurel, Martin Umbehr, et al.
Journal of the National Cancer Institute|March 11, 2026
Divergent effects of PLA2G7 on prostate cancer biochemical recurrence in european American and african American menChanning J Paller, Shuanzeng Wei, Megan Schumacher, et al.
Carcinogenesis|December 12, 2017
Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention TrialLi Tang, Mary E Platek, Song Yao, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Identifying Plasma Proteins Associated with Risk of Solid Cancers: A 25-Year Prospective Analysis of 4,712 Circulating Proteins in the ARIC StudyZiqiao Wang, Vernon Burk, Zhe Huang, et al.
Pageof 59